2010, Número 3
<< Anterior Siguiente >>
Rev Invest Clin 2010; 62 (3)
Osteoartropatía hipertrófica: Linaje, orígenes y textura
Martínez-Lavín M, Pineda VC
Idioma: Español
Referencias bibliográficas: 29
Paginas: 261-266
Archivo PDF: 55.03 Kb.
FRAGMENTO
Mujer de 44 años de edad. Fumadora de un paquete
de cigarrillos diario durante los últimos 20
años.
Inició su padecimiento cuatro años antes del diagnóstico
con dolor en piernas que lentamente fue progresando
en intensidad, el dolor después abarcó
también los brazos.
REFERENCIAS (EN ESTE ARTÍCULO)
Martínez-Lavín M, Matucci-Cerinic M, Jajic I, Pineda C. Hypertrophic osteoarthropathy: Consensus on its definition, classification, assessment and diagnostic criteria. J Rheumatol 1993; 20: 1386-7.
Marie P. De l’ostéo-arthropathie hypertrophiante pneumique Rev Med 1890; 10: 1-36.
Martinez-Lavin M. Hypertrophic osteoarthropathy. 4th. Ed. In: Hochberg M, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds.). Rheumatology. Edinburg: Mosby; 2007.
Martínez-Lavín M, Mansilla J, Pineda C, Pijoán C, Ochoa P. Evidence of hypertrophic osteoarthropathy in human skeletal remains from prehispanic Mesoamerica. Ann Intern Med 1994; 120: 238-41.
Martínez-Lavín M, Pineda C, Valdez T, Cajigas JC, Weisman M. Primary hypertrophic osteoarthropathy. Sem Arthritis Rheum 1988; 17: 156-62.
Martínez-Lavín M, Bobadilla M, Casanova J, Attié F, Martínez M. Hypertrophic osteoarthropathy in cyanotic heart disease: Its prevalence and relationship to bypass of the lung. Arthritis Rheum 1982; 25: 1186-93.
Currie AE, Gallagher PJ. The pathology of clubbing: Vascular changes in the nail bed. Br J Dis Chest 1988; 82: 382-5.
Martinez-Lavin M. Exploring the cause of the oldest clinical sign of medicine; finger clubbing. Semin Arthritis Rheum 2007; 36: 380-5.
Martínez-Lavín M. Digital clubbing and hypertrophic osteoarthropathy: A unifying hypothesis. J Rheumatol 1987; 14: 6-8.
Dickinson C, Martin J. Megakaryocyte and platelet clumps as cause of finger clubbing. Lancet 1987; 11: 1434-5.
Matucci-Cerinic M, Martínez-Lavín M, Rojo F, Fonseca C, Kahaleh B. von Willebrand factor in hypertrophic osteoarthropathy. J Rheumatol 1992; 19: 765-7.
Vazquez-Abad D, Martínez-Lavín M. Macrothrombocytes in the peripheral circulation of patients with cardiogenic hypertrophic osteoarthropathy. Clin Exp Rheumatol 1991; 9: 59-62.
Fonseca C, Martínez-Lavín M, Hernandez-Rodriguez N, Osornio- Vargas A. Circulating plasma levels of platelet-derived growth factor in patients with hypertrophic osteoarthropathy. Clin Exp Rheumatol 1992; 10(Suppl. 7): 73.
Martínez-Lavín M, Vargas AS, Cabré J, Nava A, Silveira LH, Amigo MC, Pineda C. Features oh hypertrophic osteoarthropathy in patients with POEMS syndrome: A metaanalysis. J Rheumatol 1997; 24: 2267-8.
Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I, Authier FJ, Gherardi RK. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996; 347: 702.
Soubrier M, Dubost JJ, Serre AF, Ristori JM, Sauvezie B, Cathebras P, Piette JC, Chapman A. Growth factors in POEMS syndrome: Evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum 1997; 40: 786-7.
Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25: 581-611.
Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13: 9-22.
Silveira LH, Martínez-Lavín M, Pineda C, Fonseca MC, Navarro C, Nava A. Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol 2000; 18: 57-62.
Silveira LH, Martínez-Lavín M, Pineda C, Fonseca MC, Navarro C, Nava A. Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol 2000; 18: 57-62.
Atkinson S, Fox SB. Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol 2004; 203: 721-8.
Uppal S, Diggle CP, Carr IM, Fishwick CW, Ahmed M, Ibrahim GH, Helliwell PS, Latos-Bielenska A, Phillips SE, Markham AF, Bennett CP, Brnthron DT. Muations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet 2008; 40: 789-93.
Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, Rodan SB. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 1994; 93: 2490-6.
Pineda C, Weisman M, Guerra A, Resnick D, Martínez-Lavín M. The skeletal manifestations of clubbing: a study in patients with cyanotic heart disease and hypertrophic osteoarthropathy. Sem Arthritis Rheum 1985; 14: 263-7.
Pineda C, Fonseca C, Martínez-Lavín M. The spectrum of soft tissue and skeletal abnormalities of hypertrophic osteoarthropathy. J Rheumatol 1990; 17: 626-32.
Pineda C, Martínez-Lavín M, Goobar J, Sartoris D, Clopton P, Resnick D. Periostitis in hypertrophic osteoarthropathy: Rela tionship to diseases duration. AM J Roentgenol 1987; 148: 773-8.
Pineda C. Diagnostic imaging in hypertrophic osteoarthropathy. Clin Exp Rheumatol 1992; 10(Suppl.): 27-34.
Gall E, Bennett GA, Bauer W. Generalized hypertrophic osteoarthropathy: A pathologic study of seven cases. Am J Pathol 1951; 27: 349-81.
Jajiæ Z, Jajiæ I, Nemcic T. Primary hypertrophic osteoarthropathy: Clinical, radiologic, and scintigraphic characteristics. Arch Med Research 2001; 32: 136-42.